Zum Hauptinhalt wechseln

Scientific Expertise

Posters  —  17 April Apr 2023

Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model

Read More about Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model
Posters  —  17 April Apr 2023

Enhanced detection and classification of cell-free DNA alterations through matched normal analyses with PGDx elio plasma complete

Read More about Enhanced detection and classification of cell-free DNA alterations through matched normal analyses with PGDx elio plasma complete
Posters  —  17 April Apr 2023

A novel technique to preclinically assess the ability of targeted therapies to inhibit both primary and metastatic non-small cell lung carcinoma 

Read More about A novel technique to preclinically assess the ability of targeted therapies to inhibit both primary and metastatic non-small cell lung carcinoma 
 —  14 April Apr 2023

Validation of the Labcorp Plasma Focus test to facilitate precision oncology through cell-free DNA genomic profiling of solid tumors

Read More about Validation of the Labcorp Plasma Focus test to facilitate precision oncology through cell-free DNA genomic profiling of solid tumors
Posters  —  4 November Nov 2022

Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency

Read More about Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency
Posters  —  1 July Jul 2022

LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers

Read More about LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers
Press Releases  —  2 June Jun 2022

Labcorp expands access to comprehensive genomic testing through new lung cancer program

Read More about Labcorp expands access to comprehensive genomic testing through new lung cancer program
Press Releases  —  19 April Apr 2022

Labcorp enhances cell and gene therapy development support through collaboration with Xcell Biosciences

Read More about Labcorp enhances cell and gene therapy development support through collaboration with Xcell Biosciences
Posters  —  1 March Mar 2022

Checkpoint coexpression landscape in gastroesophageal adenocarcinoma

Read More about Checkpoint coexpression landscape in gastroesophageal adenocarcinoma
Articles  —  12 January Jan 2022

GenomOncology Pathology Workbench to support OmniSeq INSIGHT℠, a genomic and immune profiling test that identifies potential treatment and clinical trial options for solid tumors

Read More about GenomOncology Pathology Workbench to support OmniSeq INSIGHT℠, a genomic and immune profiling test that identifies potential treatment and clinical trial options for solid tumors
Press Releases  —  23 December Dec 2021

Labcorp strengthens oncology leadership position with the addition of Personal Genome Diagnostics, a provider of comprehensive liquid biopsy and tissue-based genomic products and services

Read More about Labcorp strengthens oncology leadership position with the addition of Personal Genome Diagnostics, a provider of comprehensive liquid biopsy and tissue-based genomic products and services
 —  2 December Dec 2021

A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors

Read More about A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors